Total numbers of neurons and glial cells in cortex and basal ganglia of aged brains with down syndrome-a stereological study

Cerebral Cortex

Volumn 21, Issue 11, 2011, Pages 2519-2524

  Karlsen, Anna Schou ^a   Pakkenberg, Bente ^a  

^a Mental Health Services CPH   (Denmark)

Author keywords

aging; cell number; mental impairment; stereology; trisomy 21

Indexed keywords

ADULT; AGED; AGING; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN NERVE CELL; BRAIN REGION; BRAIN SIZE; CASE REPORT; CELL COUNT; CELL DENSITY; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GLIA CELL; HUMAN; NEOCORTEX; OLIGODENDROGLIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STEREOLOGY;

AGED; AGING; BASAL GANGLIA; CELL COUNT; CEREBRAL CORTEX; DOWN SYNDROME; FEMALE; HUMANS; MIDDLE AGED; NEUROGLIA; NEURONS;

EID: 80053492397     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhr033     Document Type: Article

References (35)

1. Aylward EH, Li Q, Habbak QR, Warren A, Pulsifer MB, Barta PE, Jerram M, Pearlson G. 1997. Basal ganglia volume in adults with Down syndrome. Psychiatry Res. 74:73-82. (Pubitemid 27288516)
2. Bartzokis G, Beckson M, Hance DB, Marx P, Foster JA, Marder SR. 1997. MR evaluation of age-related increase of brain iron in young adult and older normal males. Magn Reson Imaging. 15:29-35. (Pubitemid 27143746)
3. Bartzokis G, Mintz J, Sultzer D, Marx P, Herzberg JS, Phelan CK, Marder SR. 1994. In vivo MR evaluation of age-related increases in brain iron. AJNR Am J Neuroradiol. 15:1129-1138. (Pubitemid 24184373)
4. Bondi MW, Jak AJ, Delano-Wood L, Jacobson MW, Delis DC, Salmon DP. 2008. Neuropsychological contributions to the early identification of Alzheimer's disease. Neuropsychol Rev. 18:73-90.
5. Bundgaard MJ, Regeur L, Gundersen HJ, Pakkenberg B. 2001. Size of neocortical neurons in control subjects and in Alzheimer's disease. J Anat. 198:481-489. (Pubitemid 32390379)
6. Contestabile A, Benfenati F, Gasparini L. 2010. Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome. Prog Neurobiol. 91:1-22.
7. Contestabile A, Fila T, Ceccarelli C, Bonasoni P, Bonapace L, Santini D, Bartesaghi R, Ciani E. 2007. Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neo-cortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice. Hippocampus. 17:665-678. (Pubitemid 47292037)
8. Coppus AM, Evenhuis HM, Verberne GJ, Visser FE, Oostra BA, Eikelenboom P, van Gool WA, Janssens AC, van Duijn CM. 2008. Survival in elderly persons with Down syndrome. J Am Geriatr Soc. 56:2311-2316.
9. Delabar JM, Aflalo-Rattenbac R, Creau N. 2006. Developmental defects in trisomy 21 and mouse models. ScientificWorldJournal. 6:1945-1964.
10. Encha-Razavi F, Sonigo P. 2003. Features of the developing brain. Childs Nerv Syst. 19:426-428. (Pubitemid 37161583)
11. Gundersen HJ. 1985. Stereology and sampling of biological surfaces. The analysis of organic and biological surfaces. New York: John Wiley and Sons Inc. p. 477-506.
12. Gundersen HJ. 1986. Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson. J Microsc. 143:3-45.
13. Gundersen HJ, Jensen EB. 1987. The efficiency of systematic sampling in stereology and its prediction. J Microsc. 147:229-263.
14. Gundersen HJ, Jensen EB, Kieu K, Nielsen J. 1999. The efficiency of systematic sampling in stereology-reconsidered. J Microsc. 193: 199-211.
15. Hof PR, Bouras C, Perl DP, Sparks DL, Mehta N, Morrison JH. 1995. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Arch Neurol. 52:379-391.
16. Kornack DR, Rakic P. 1998. Changes in cell-cycle kinetics during the development and evolution of primate neocortex. Proc Natl Acad Sci USA. 95:1242-1246. (Pubitemid 28124943)
17. Kress GJ, Dineley KE, Reynolds IJ. 2002. The relationship between intracellular free iron and cell injury in cultured neurons, astrocytes, and oligodendrocytes. J Neurosci. 22:5848-5855. (Pubitemid 35387629)
18. Larsen KB, Laursen H, Graem N, Samuelsen GB, Bogdanovic N, Pakkenberg B. 2008. Reduced cell number in the neocortical part of the human fetal brain in Down syndrome. Ann Anat. 190:421-427.
19. Oster S, Christoffersen P, Gundersen HJ, Nielsen JO, Pakkenberg B, Pedersen C. 1993. Cerebral atrophy in AIDS: a stereological study. Acta Neuropathol. 85:617-622. (Pubitemid 23212028)
20. Pakkenberg B, Gundersen HJ. 1997. Neocortical neuron number in humans: effect of sex and age. J Comp Neurol. 384:312-320. (Pubitemid 27282046)
21. Pelvig DP, Pakkenberg H, Regeur L, Oster S, Pakkenberg B. 2003. Neocortical glial cell numbers in Alzheimer's disease. A stereological study. Dement Geriatr Cogn. 16:212-219. (Pubitemid 37188116)
22. Pelvig DP, Pakkenberg H, Stark AK, Pakkenberg B. 2008. Neocortical glial cell numbers in human brains. Neurobiol Aging. 29:1754-1762.
23. Pinter JD, Eliez S, Schmitt JE, Capone GT, Reiss AL. 2001. Neuroanatomy of Down's syndrome: a high-resolution MRI study. Am J Psychiatry. 158:1659-1665. (Pubitemid 32923659)
24. Rakic P. 1995. A small step for the cell, a giant leap for mankind: a hypothesis of neocortical expansion during evolution. Trends Neurosci. 18:383-388.
25. Raz N, Torres IJ, Briggs SD, Spencer WD, Thornton AE, Loken WJ, Gunning FM, McQuain JD, Driesen NR, Acker JD. 1995. Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry. Neurology. 45:356-366.
26. Regeur L, Jensen GB, Pakkenberg H, Evans SM, Pakkenberg B. 1994. No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type. Neurobiol Aging. 15: 347-352. (Pubitemid 24194876)
27. Ross MH, Galaburda AM, Kemper TL. 1984. Down's syndrome: is there a decreased population of neurons? Neurology. 34:909-916. (Pubitemid 14076456)
28. Roth GM, Sun B, Greensite FS, Lott IT, Dietrich RB. 1996. Premature aging in persons with Down syndrome: MR findings. AJNR Am J Neuroradiol. 17:1283-1289. (Pubitemid 26277366)
29. Sweeney JE, Hohmann CF, Oster-Granite L, Coyle JT. 1989. Neuro-genesis of the basal forebrain in euploid and trisomy 16 mice: an animal model for developmental disorders in Down syndrome. Neuroscience. 31:413-425. (Pubitemid 19238647)
30. Stankiewicz JM, Brass SD. 2009. Role of iron in neurotoxicity: a cause for concern in the elderly? Curr Opin Clin Nutr. 12:22-29.
31. Uylings HBM, van Eden CG, Hofman MA. 1986. Morphometry of size/volume variables and comparison of their bivariate relations in the nervous system under different conditions. J Neurosci Methods. 18:19-37. (Pubitemid 17183606)
32. Wisniewski KE. 1990. Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. Am J Med Genet Suppl. 7:274-281.
33. Wisniewski KE, Wisniewski HM, Wen GY. 1985. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol. 17:278-282. (Pubitemid 15136603)
34. Yang Q, Rasmussen SA, Friedman JM. 2002. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet. 359:1019-1025. (Pubitemid 34286539)
35. Zhang X, Haaf M, Todorich B, Grosstephan E, Schieremberg H, Surguladze N, Connor JR. 2005. Cytokine toxicity to oligodendro-cyte precursors is mediated by iron. Glia. 52:199-208. (Pubitemid 43078509)